REGULATED PRESS RELEASE published on 11/12/2024 at 08:47, 1 year 9 months ago Laboratoires Euromedis - Lancement d'une OCA avec maintien du DPS
BRIEF published on 10/28/2024 at 18:23, 1 year 10 months ago Euromedis Groupe : Résultats Semestriels 2024 Chiffre D'affaires Résultats Semestriels Marge Brute Géopolitique Euromedis
BRIEF published on 10/28/2024 at 18:23, 1 year 10 months ago Euromedis Group: Half-Year Results 2024 Gross Margin Half-year Results Turnover Geopolitics Euromedis
BRIEF published on 10/28/2024 at 18:20, 1 year 10 months ago Analysis of the Euromedis Laboratories Half-Year Financial Report as of June 30, 2024 Reorganization Turnover Half-yearly Finances Euromedis Laboratories Transportation Costs
BRIEF published on 10/28/2024 at 18:20, 1 year 10 months ago Analyse du Rapport Financier Semestriel de Laboratoires Euromedis au 30 juin 2024 Chiffre D'affaires Reorganisation Laboratoires Euromedis Finances Semestrielles Coûts De Transport
REGULATED PRESS RELEASE published on 10/28/2024 at 18:18, 1 year 10 months ago Euromedis - Communiqué semestriel 2024 Annonce des résultats semestriels 2024 de Laboratoires Euromedis après fusion avec Euromedis Groupe, soulignant l'effet des tensions géopolitiques et les perspectives de réorganisation pour le second semestre Tensions Géopolitiques Résultats Semestriels 2024 Fusion Sociétés Réorganisation Société Perspectives Second Semestre 2024
REGULATED PRESS RELEASE published on 10/28/2024 at 18:15, 1 year 10 months ago Rapport Financier Semestriel - 30/06/2024 Rapport financier semestriel de SA Laboratoires Euromedis pour le 30 juin 2024, incluant les comptes, événements marquants, risques et perspectives. Fusion avec Euromedis Groupe. Analyse des résultats et prévisions Perspectives Rapport Financier Comptes Semestriels 30 Juin 2024 SA Laboratoires Euromedis
REGULATED PRESS RELEASE published on 04/30/2024 at 18:25, 2 years 4 months ago Rapport financier annuel 2023
BRIEF published on 04/26/2024 at 18:53, 2 years 4 months ago Euromedis Groupe publie ses résultats annuels pour 2023 Prévisions 2024 Résultats Financiers 2023 Impact Géopolitique Euromedis Groupe Fusion Entreprise
BRIEF published on 04/26/2024 at 18:53, 2 years 4 months ago Euromedis Groupe publishes its annual results for 2023 2023 Financial Results Forecast 2024 Geopolitical Impact Euromedis Group Company Merger
Published on 09/11/2026 at 04:00, 3 hours 11 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 8 hours 46 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 15 hours 51 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 16 hours 11 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 00:05, 7 hours 5 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/11/2026 at 00:01, 7 hours 10 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/10/2026 at 22:39, 8 hours 31 minutes ago EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law
Published on 09/10/2026 at 22:07, 9 hours 3 minutes ago EQS-Adhoc: flatexDEGIRO SE: Changes to the Supervisory Board
Published on 09/11/2026 at 07:00, 11 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 11 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 11 hours 41 minutes ago Availability of the 2026 Interim Financial Report
